Coincidence Technologies is now part of GE Medical Systems, and Kretztechnik is within a hair of joining it. Belgium-based Coincidence Technologies brings to GE technology for efficient manufacture of the PET radiopharmaceutical fluorodeoxyglucose (FDG)
Coincidence Technologies is now part of GE Medical Systems, and Kretztechnik is within a hair of joining it. Belgium-based Coincidence Technologies brings to GE technology for efficient manufacture of the PET radiopharmaceutical fluorodeoxyglucose (FDG) (SCAN 9/5/01). A synthesizer is used in conjunction with a cyclotron, providing the final chemical steps in producing the FDG. Austria-based Kretztechnik develops 3-D ultrasound systems. GE has acquired the 65.4% of Kretztechnik shares held by Medison, as well as another 27.1% of the company’s outstanding shares. These transactions provide GE with 92.5% ownership in Kretztechnik. After GE acquires the remaining shares, Kretztechnik will become a wholly owned subsidiary.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.